New Delhi, May 28 -- Zydus Lifesciences, on Wednesday, 27 May, announced that its buyback committee has approved revisions to the company's ongoing share buyback programme, including an increase in the buyback price and a reduction in the number of shares to be repurchased.

The company said the buyback price has been raised to Rs.1,260 per equity share from Rs.1,150 per equity share earlier.

At the same time, the maximum number of equity shares proposed to be bought back has been lowered from 95.65 lakh shares to 87.30 lakh shares, which represents up to 0.87% of the company's total paid-up equity share capital.

Zydus Lifesciences added that the buyback will continue to be carried out through the tender offer route at a total considera...